Vectorialis

Vectorialis is at the forefront of developing groundbreaking technologies for advanced therapies and recombinant protein production. Our cutting-edge solutions leverage the powerful VibroFect technology, which produces high-performing and safe non-viral nanoparticles that encapsulate nucleic acids. This innovative system includes i) a patented bench-top device that ensures optimal mixing of your selected nucleic acids, and ii) the proprietary VibroFect transfection reagent. VibroFect technology stands out for its exceptional transfection efficiency with nucleic acid-based payloads, making it suitable for a broad spectrum of both hard-to-transfect and common eukaryotic cells. With remarkably low cytotoxicity, our approach minimizes the requisite amounts of both reagent and nucleic acids, ensuring not only effectiveness but also safety in your applications.